Delivra Health Brands Stock Probability of Future OTC Stock Price Finishing Under 0.0312

DHBUF Stock  USD 0.01  0.0001  0.85%   
Delivra Health's future price is the expected price of Delivra Health instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Delivra Health Brands performance during a given time horizon utilizing its historical volatility. Check out Delivra Health Backtesting, Delivra Health Valuation, Delivra Health Correlation, Delivra Health Hype Analysis, Delivra Health Volatility, Delivra Health History as well as Delivra Health Performance.
  
Please specify Delivra Health's target price for which you would like Delivra Health odds to be computed.

Delivra Health Target Price Odds to finish below 0.0312

The tendency of Delivra OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.03  after 90 days
 0.01 90 days 0.03 
close to 99
Based on a normal probability distribution, the odds of Delivra Health to stay under $ 0.03  after 90 days from now is close to 99 (This Delivra Health Brands probability density function shows the probability of Delivra OTC Stock to fall within a particular range of prices over 90 days) . Probability of Delivra Health Brands price to stay between its current price of $ 0.01  and $ 0.03  at the end of the 90-day period is about 85.65 .
Assuming the 90 days horizon Delivra Health Brands has a beta of -0.44 suggesting as returns on the benchmark increase, returns on holding Delivra Health are expected to decrease at a much lower rate. During a bear market, however, Delivra Health Brands is likely to outperform the market. Additionally Delivra Health Brands has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Delivra Health Price Density   
       Price  

Predictive Modules for Delivra Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Delivra Health Brands. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Delivra Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.017.28
Details
Intrinsic
Valuation
LowRealHigh
0.000.017.28
Details

Delivra Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Delivra Health is not an exception. The market had few large corrections towards the Delivra Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Delivra Health Brands, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Delivra Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.74
β
Beta against Dow Jones-0.44
σ
Overall volatility
0
Ir
Information ratio -0.1

Delivra Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Delivra Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Delivra Health Brands can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Delivra Health generated a negative expected return over the last 90 days
Delivra Health has high historical volatility and very poor performance
Delivra Health has some characteristics of a very speculative penny stock
Delivra Health has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 8.14 M. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 2.6 M.
Delivra Health Brands has accumulated about 1.67 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 22.0% of the company shares are held by company insiders

Delivra Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Delivra OTC Stock often depends not only on the future outlook of the current and potential Delivra Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Delivra Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding252.6 M

Delivra Health Technical Analysis

Delivra Health's future price can be derived by breaking down and analyzing its technical indicators over time. Delivra OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Delivra Health Brands. In general, you should focus on analyzing Delivra OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Delivra Health Predictive Forecast Models

Delivra Health's time-series forecasting models is one of many Delivra Health's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Delivra Health's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Delivra Health Brands

Checking the ongoing alerts about Delivra Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Delivra Health Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Delivra Health generated a negative expected return over the last 90 days
Delivra Health has high historical volatility and very poor performance
Delivra Health has some characteristics of a very speculative penny stock
Delivra Health has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 8.14 M. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 2.6 M.
Delivra Health Brands has accumulated about 1.67 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 22.0% of the company shares are held by company insiders

Other Information on Investing in Delivra OTC Stock

Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.